GlassScriptPhysician profile
Marcin J Bujak
NPI 1811158983
$2,066.83
in general payments reported to CMS, 2019-2025
24 companies · $795 in 2025
The $795 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.76 · 2020: $340 · 2021: $62.48 · 2022: $423 · 2023: $171 · 2024: $217 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $313.92 | 2019-2025 | Bodyguardian, Watchman Flx |
| Edwards Lifesciences Corporation | $311.57 | 2020-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $223.51 | 2022-2024 | |
| Abbott Laboratories | $149.09 | 2025 | Aveir, Cardiomems |
| Cardiva Medical, INC. | $137.82 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.46 | 2020-2024 | Lifevest |
| Abiomed | $123.01 | 2025 | |
| Imperative Care, INC | $94.79 | 2025 | Symphony Catheter |
| Philips North America LLC | $92.70 | 2023-2025 | Coronary Other |
| Novo Nordisk INC | $79.12 | 2022-2025 | |
| Amarin Pharma, INC. | $53.53 | 2020-2021 | |
| Angiodynamics, INC. | $53.14 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $47.49 | 2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $42.47 | 2022 | |
| Cardiovascular Systems INC. | $40.82 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $38.05 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $27.87 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $21.61 | 2020 | |
| Biotronik INC. | $19.42 | 2019 | |
| Amgen INC. | $15.65 | 2025 | Repatha |
| Actelion Pharmaceuticals US, INC. | $15.61 | 2020 | |
| Innovation Technologies INC | $15.19 | 2025 | Irrisept |
| Agepha Pharma Fz LLC | $13.02 | 2024 | Lodoco |
| Merck Sharp & Dohme LLC | $12.97 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcin Bujak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.